Ginkgo Bioworks Holdings (DNA) Change in Receivables (2020 - 2026)
Ginkgo Bioworks Holdings posted quarterly Change in Receivables of $242000.0 for Q1 2026, down 63.72% year-on-year from $667000.0 in Q1 2025, and down 86.69% on a QoQ basis from $1.8 million in Q4 2025.
Ginkgo Bioworks Holdings (DNA) has 7 years of Change in Receivables data on file, last reported at $242000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables fell 63.72% year-over-year to $242000.0; the trailing twelve-month figure through Mar 2026 stood at $1.0 million (up 176.05% YoY), and the FY2025 full-year result was $1.5 million, down 68.83% from the prior year.
- Change in Receivables for Q1 2026 stood at $242000.0, down from $1.8 million in the prior quarter.
- Across five years, Change in Receivables topped out at $34.9 million in Q1 2022 and bottomed at -$59.1 million in Q3 2022.
- The 5-year median for Change in Receivables is -$255000.0 (2025), against an average of -$5.8 million.
- The widest annual swing landed in 2023, when Change in Receivables slumped 533.87%; it then jumped 1187.07% in 2024.
- A 5-year view of Change in Receivables shows it stood at -$34.5 million in 2022, then increased by 16.24% to -$28.9 million in 2023, then jumped by 95.24% to -$1.4 million in 2024, then surged by 232.12% to $1.8 million in 2025, then tumbled by 86.69% to $242000.0 in 2026.
- The last three Change in Receivables figures came in at $242000.0 (Q1 2026), $1.8 million (Q4 2025), and -$757000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 208,524.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -39.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 110.42 Mn |
| 10 | Ginkgo Bioworks Holdings | 542.03 Mn | 542.03 Mn | 16.38 Mn | 242,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 242,000.00 |
| Mar 31, 2026 | 242,000.00 |
| Dec 31, 2025 | 1.82 Mn |
| Dec 31, 2025 | 1.82 Mn |
| Sep 30, 2025 | -757,000.00 |
| Sep 30, 2025 | -757,000.00 |
| Jun 30, 2025 | -255,000.00 |
| Jun 30, 2025 | -255,000.00 |
| Mar 31, 2025 | 667,000.00 |
| Mar 31, 2025 | 667,000.00 |
| Dec 31, 2024 | -1.38 Mn |
| Dec 31, 2024 | -1.38 Mn |
| Sep 30, 2024 | 5.00 Mn |
| Sep 30, 2024 | 5.00 Mn |
| Jun 30, 2024 | -5.67 Mn |
| Jun 30, 2024 | -5.67 Mn |
| Mar 31, 2024 | 6.77 Mn |
| Mar 31, 2024 | 6.77 Mn |
| Dec 31, 2023 | -28.90 Mn |
| Dec 31, 2023 | -28.90 Mn |
| Sep 30, 2023 | -5.77 Mn |
| Sep 30, 2023 | -5.77 Mn |
| Jun 30, 2023 | -15.92 Mn |
| Jun 30, 2023 | -15.92 Mn |
| Mar 31, 2023 | 526,000.00 |
| Mar 31, 2023 | 526,000.00 |
| Dec 31, 2022 | -34.50 Mn |
| Dec 31, 2022 | -34.50 Mn |
| Sep 30, 2022 | -59.12 Mn |
| Sep 30, 2022 | -59.12 Mn |
| Jun 30, 2022 | 3.67 Mn |
| Jun 30, 2022 | 3.67 Mn |
| Mar 31, 2022 | 34.93 Mn |
| Mar 31, 2022 | 34.93 Mn |
| Dec 31, 2021 | 85.42 Mn |
| Dec 31, 2021 | 85.42 Mn |
| Sep 30, 2021 | 22.19 Mn |
| Sep 30, 2021 | 22.19 Mn |
| Jun 30, 2021 | -3.06 Mn |
| Jun 30, 2021 | -3.06 Mn |
| Mar 31, 2021 | 9.54 Mn |
| Mar 31, 2021 | 9.54 Mn |
| Dec 31, 2020 | 13.78 Mn |
| Dec 31, 2020 | 13.78 Mn |